Medelis is a specialty oncology CRO focused on preclinical and phase 1 through phase 3 oncology trials in North America and Europe. Founded in 2003, Medelis provides sponsors with oncology expertise from drug development thought-leadership to a highly skilled clinical operations team, handling complex oncology trials in all indications, including cutting-edge immunotherapy treatments.
Looking for a particular Medelis, Inc. employee's phone or email?
The Medelis, Inc. annual revenue was $25.9 million in 2026.
Brad Phillips is the Vice President of Clinical Operations of Medelis, Inc..
20 people are employed at Medelis, Inc..
Medelis, Inc. is based in Nashville, Tennessee.
The NAICS codes for Medelis, Inc. are [54, 5417, 541].
The SIC codes for Medelis, Inc. are [873, 87].